Amesite Inc. (NASDAQ: AMST) is a technology company that builds and commercializes AI-powered SaaS solutions for the healthcare sector, with a focus on the post-acute care market. Revenue comes from subscription fees under a SaaS model, targeting both individual users (B2C) and business customers (B2B) in post-acute care settings. The company completed a pivot away from an education-centered business model in fiscal year 2025. Its primary product, NurseMagic, addresses documentation, workflow automation, and compliance for nurses and caregivers. Amesite reported net losses of approximately $3,617,000 and $4,403,000 for the fiscal years ended June 30, 2025 and June 30, 2024, respectively. The company carries a going concern qualification as of the 10-K filed September 29, 2025, with management acknowledging insufficient cash to maintain planned operations for the twelve months following that filing date. Amesite is headquartered in the United States and operates as a single entity with no disclosed subsidiaries.
NurseMagic, an AI-powered application for nurses and caregivers covering documentation, workflow automation, and compliance. The product requires no external system integration and is administered within the app. Amesite previously offered education-centered products before pivoting to healthcare AI in FY2025.
SaaS subscription fees from B2B enterprise customers in post-acute care and B2C individual nurse and caregiver subscribers. A free version of NurseMagic is offered to individual users to drive adoption, with paid tiers targeting business customers. The company has not yet established a stable, recurring revenue base sufficient to cover ongoing expenses as of FY2025.
Individual nurses and caregivers (B2C) and post-acute care businesses (B2B). End market is the post-acute care segment of the healthcare sector. The company is in early stages of building its customer base as of FY2025.
United States. No international operations or geographic revenue breakdown disclosed in the filing excerpts.
Loading...